Cargando…

Integrative pan-cancer landscape of MMS22L and its potential role in hepatocellular carcinoma

Methyl methanesulfonate-sensitivity protein 22-like (MMS22L) is crucial in protecting genome integrity during DNA replication by preventing DNA damage and maintaining efficient homologous recombination. However, the role of MMS22L in human cancers remains unclear. Here, we reported the landscape of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Zhiting, Liu, Fahui, Gong, Qiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582350/ https://www.ncbi.nlm.nih.gov/pubmed/36276962 http://dx.doi.org/10.3389/fgene.2022.1025970

Ejemplares similares

Mms1 and Mms22 stabilize the replisome during replication stress
por: Vaisica, Jessica A., et al.
Publicado: (2011)

Machine learning-based integration develops a neutrophil-derived signature for improving outcomes in hepatocellular carcinoma
por: Gong, Qiming, et al.
Publicado: (2023)

Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency
por: Saxena, Parima, et al.
Publicado: (2023)

CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma
por: Gong, Qiming, et al.
Publicado: (2022)

MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma
por: Luo, Qiyu, et al.
Publicado: (2021)

The SOX9-MMS22L Axis Promotes Oxaliplatin Resistance in Colorectal Cancer
por: Liu, Yiqiang, et al.
Publicado: (2021)

Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers
por: Wang, Hengzhen, et al.
Publicado: (2021)

The Role of Mms22p in DNA Damage Response in Candida albicans
por: Yan, Lan, et al.
Publicado: (2015)

An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy
por: Feng, Mingtao, et al.
Publicado: (2022)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Integrated pan-cancer analysis of CSMD2 as a potential prognostic, diagnostic, and immune biomarker
por: Zhang, Huiyun, et al.
Publicado: (2022)

Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods
por: Li, Zhuolin, et al.
Publicado: (2021)

Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments
por: Hu, Xueting, et al.
Publicado: (2022)

MMS22L-TONSL functions in sister chromatid cohesion in a pathway parallel to DSCC1-RFC
por: van Schie, Janne JM, et al.
Publicado: (2022)

Pyroptosis-Related Risk Signature Exhibits Distinct Prognostic, Immune, and Therapeutic Landscapes in Hepatocellular Carcinoma
por: Zhao, Yidi, et al.
Publicado: (2022)

Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer
por: Wang, Na, et al.
Publicado: (2022)

Multi-omics analysis reveals a molecular landscape of the early recurrence and early metastasis in pan-cancer
por: He, Dan-ni, et al.
Publicado: (2023)

Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
por: Wei, Wei, et al.
Publicado: (2022)

Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma
por: Lu, Qian, et al.
Publicado: (2022)

Clinical Significance and Potential Role of LSM4 Overexpression in Hepatocellular Carcinoma: An Integrated Analysis Based on Multiple Databases
por: Chen, Liang, et al.
Publicado: (2022)

The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
por: Wei, Zhiting, et al.
Publicado: (2019)

Differential Integration of Transcriptome and Proteome Identifies Pan-Cancer Prognostic Biomarkers
por: Schwartz, Gregory W., et al.
Publicado: (2018)

Integrative analysis of the role of BOLA2B in human pan-cancer
por: Liang, Mingxing, et al.
Publicado: (2023)

Integrative multiomics evaluation reveals the importance of pseudouridine synthases in hepatocellular carcinoma
por: Jin, Zhipeng, et al.
Publicado: (2022)

Integrated analysis reveals common DNA methylation patterns of alcohol-associated cancers: A pan-cancer analysis
por: Liu, Xingyu, et al.
Publicado: (2023)

Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma
por: Gong, Qiming, et al.
Publicado: (2023)

Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma
por: Sun, Rui, et al.
Publicado: (2022)

Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma
por: Wang, Liangliang, et al.
Publicado: (2022)

Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learning
por: Wang, Jiaying, et al.
Publicado: (2022)

Mms22p protects Saccharomyces cerevisiae from DNA damage induced by topoisomerase II
por: Baldwin, E. L., et al.
Publicado: (2005)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

A pan-cancer analysis of copper homeostasis-related gene lipoyltransferase 1: Its potential biological functions and prognosis values
por: Liu, Ying, et al.
Publicado: (2022)

The Prognostic Significance and Potential Mechanism of Ferroptosis-Related Genes in Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

The association of XPG and MMS19L polymorphisms response to chemotherapy in osteosarcoma
por: Zhao, Yi-lei, et al.
Publicado: (2013)

An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers
por: Lan, Chungen, et al.
Publicado: (2022)

Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma
por: Tang, Hong, et al.
Publicado: (2022)

Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma
por: Li, Debao, et al.
Publicado: (2023)

Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma
por: Sun, Renliang, et al.
Publicado: (2020)

miR-22-3p as a potential biomarker for coronary artery disease based on integrated bioinformatics analysis
por: Zhang, Minghua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dapq8ko19s1i8deivjhe85ng91